Stocks · Health care · Pharmaceutical Preparations

Immuneering Corp

IMRX Clue Score35
United States Fiscal year ends December CIK 0001790340 Results filed 29 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
398,600
$2.90
$1.16M
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
280
$2.97
$831.60
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
10
$2.98
$29.80
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
10
$3.01
$30.10
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
600
$3.03
$1.82K
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
100
$3.05
$305.00
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
300
$3.07
$919.50
Cormorant Asset Management, LP
1 Apr 2024
10% owner
Sell indirect
100
$3.07
$307.00
Cormorant Asset Management, LP
15 Mar 2024
10% owner
Sell indirect
400,000
$2.14
$856.40K
Cormorant Asset Management, LP
14 Mar 2024
10% owner
Sell indirect
11,040
$5.97
$65.89K
Cormorant Asset Management, LP
14 Mar 2024
10% owner
Sell indirect
54,215
$5.37
$291.35K
Cormorant Asset Management, LP
14 Mar 2024
10% owner
Sell indirect
98,570
$4.25
$418.43K
Cormorant Asset Management, LP
14 Mar 2024
10% owner
Sell indirect
345,266
$3.24
$1.12M

What was left out

Form 4 filings counted 143
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 13
Transactions with no price 0
Shares from compensation/vesting 2,718,177
History held since 30 Jul 2021